ANTXR1 and neoplasm: The specific receptor of SVV-001 was recently discovered when Miles et al. (2017) performed genome wide loss of function screens and identified anthrax toxin receptor 1 (ANTXR1), also known as tumor endothelial marker 8 (TEM8), as the receptor for SVV-001 on tumor cells.